Genuine Question so please do not bite my head off
Post# of 72440
Genuine Question so please do not bite my head off.
In your opinion do you think that this statement means Kevetrin is being tested with several different combinations???
and with sunitnib combination first tumor shrinkage was noted.
Or does it mean first time they noted shrinkage in a renal cancer tumor?
" Research by BIDMC combined Kevetrin™ with sunitinib on cell line 786, a drug-resistant renal cancer. Cellceutix was advised by the researchers that "the Kevetrin/sunitinib combination is the first we've used in which actual tumor shrinkage is noted."
2007: Sunitinib ; The first Phase III study comparing an RTKI with cytokine therapy was published in the New England Journal of Medicine . This study showed that Sunitinib offered superior efficacy compared with interferon-? . Progression-free survival (the primary endpoint) was more than doubled. The benefit for sunitinib was significant across all major patient subgroups, including those with a poor prognosis at baseline. 28% of sunitinib patients had significant tumor shrinkage compared with only 5% of patients who received interferon-?. Although overall survival data are As of 2007 not yet mature, there is a clear trend toward improved survival with sunitinib. Patients receiving sunitinib also reported a significantly better quality of life than those treated with IFNa. [48]
(0)
(0)